Picato

Country: European Union

Language: Bulgarian

Source: EMA (European Medicines Agency)

Buy It Now

Patient Information leaflet Patient Information leaflet (PIL)
04-03-2020
Summary of Product characteristics Summary of Product characteristics (SPC)
04-03-2020
Public Assessment Report Public Assessment Report (PAR)
04-03-2020

Active ingredient:

Ингеноль mebutate

Available from:

LEO Laboratories Ltd.

ATC code:

D06BX02

INN (International Name):

ingenol mebutate

Therapeutic group:

Антибиотици и химиотерапия средства за приложение в дерматологията, други химиотерапевтическими средства

Therapeutic area:

Кератоза, актинична

Therapeutic indications:

Picato е показан за Лечение на кожата не гиперкератозные, не гипертрофический актинични кератози при възрастни.

Product summary:

Revision: 10

Authorization status:

Отменено

Authorization date:

2012-11-15

Patient Information leaflet

                                1
ПРИЛОЖЕНИЕ I
КРАТКА ХАРАКТЕРИСТИКА НА ПРОДУКТА
Лекарствен продукт с невалидно
разрешение за употреба
Лекарствен продукт с невалидно
разрешение за употреба
Лекарствен продукт с невалидно
разрешение за употреба
Лекарствен продукт с невалидно
разрешение за употреба
Лекарствен продукт с невалидно
разрешение за употреба
Лекарствен продукт с невалидно
разрешение за употреба
Лекарствен продукт с невалидно
разрешение за употреба
Лекарствен продукт с невалидно
разрешение за употреба
Лекарствен продукт с невалидно
разрешение за употреба
Лекарствен продукт с невалидно
разрешение за употреба
Лекарствен продукт с невалидно
разрешение за употреба
Лекарствен продукт с невалидно
разрешение за употреба
Лекарствен продукт с невалидно
разрешение за употреба
Лекарствен продукт с невалидно
разрешение за употреба
Лекарствен продукт с невалидно
разрешение за употреба
Лекарствен продукт с невалидно
разрешение за употреба
Лекарствен продукт с невалидно
разрешение за употреба
Лекарствен продукт с невалидно
разрешение за употреба
Лекарствен продукт с невалидно
разрешение за употреба
Лекарствен продукт с 
                                
                                Read the complete document

Summary of Product characteristics

                                1
ПРИЛОЖЕНИЕ I
КРАТКА ХАРАКТЕРИСТИКА НА ПРОДУКТА
Лекарствен продукт с невалидно
разрешение за употреба
Лекарствен продукт с невалидно
разрешение за употреба
Лекарствен продукт с невалидно
разрешение за употреба
Лекарствен продукт с невалидно
разрешение за употреба
Лекарствен продукт с невалидно
разрешение за употреба
Лекарствен продукт с невалидно
разрешение за употреба
Лекарствен продукт с невалидно
разрешение за употреба
Лекарствен продукт с невалидно
разрешение за употреба
Лекарствен продукт с невалидно
разрешение за употреба
Лекарствен продукт с невалидно
разрешение за употреба
Лекарствен продукт с невалидно
разрешение за употреба
Лекарствен продукт с невалидно
разрешение за употреба
Лекарствен продукт с невалидно
разрешение за употреба
Лекарствен продукт с невалидно
разрешение за употреба
Лекарствен продукт с невалидно
разрешение за употреба
Лекарствен продукт с невалидно
разрешение за употреба
Лекарствен продукт с невалидно
разрешение за употреба
Лекарствен продукт с невалидно
разрешение за употреба
Лекарствен продукт с невалидно
разрешение за употреба
Лекарствен продукт с 
                                
                                Read the complete document

Similar products

Active ingredient Ингеноль mebutate

Ингеноль mebutate

ATC code D06BX02

D06BX02

Marketed by LEO Laboratories Ltd.

LEO Laboratories Ltd.

INN (International Name) ingenol mebutate

ingenol mebutate

Documents in other languages

Patient Information leaflet Patient Information leaflet Spanish 04-03-2020
Summary of Product characteristics Summary of Product characteristics Spanish 04-03-2020
Public Assessment Report Public Assessment Report Spanish 04-03-2020
Patient Information leaflet Patient Information leaflet Czech 04-03-2020
Summary of Product characteristics Summary of Product characteristics Czech 04-03-2020
Public Assessment Report Public Assessment Report Czech 04-03-2020
Patient Information leaflet Patient Information leaflet Danish 04-03-2020
Summary of Product characteristics Summary of Product characteristics Danish 04-03-2020
Public Assessment Report Public Assessment Report Danish 04-03-2020
Patient Information leaflet Patient Information leaflet German 04-03-2020
Summary of Product characteristics Summary of Product characteristics German 04-03-2020
Public Assessment Report Public Assessment Report German 04-03-2020
Patient Information leaflet Patient Information leaflet Estonian 04-03-2020
Summary of Product characteristics Summary of Product characteristics Estonian 04-03-2020
Public Assessment Report Public Assessment Report Estonian 04-03-2020
Patient Information leaflet Patient Information leaflet Greek 04-03-2020
Summary of Product characteristics Summary of Product characteristics Greek 04-03-2020
Public Assessment Report Public Assessment Report Greek 04-03-2020
Patient Information leaflet Patient Information leaflet English 04-03-2020
Summary of Product characteristics Summary of Product characteristics English 04-03-2020
Public Assessment Report Public Assessment Report English 04-03-2020
Patient Information leaflet Patient Information leaflet French 04-03-2020
Summary of Product characteristics Summary of Product characteristics French 04-03-2020
Public Assessment Report Public Assessment Report French 04-03-2020
Patient Information leaflet Patient Information leaflet Italian 04-03-2020
Summary of Product characteristics Summary of Product characteristics Italian 04-03-2020
Public Assessment Report Public Assessment Report Italian 04-03-2020
Patient Information leaflet Patient Information leaflet Latvian 04-03-2020
Summary of Product characteristics Summary of Product characteristics Latvian 04-03-2020
Public Assessment Report Public Assessment Report Latvian 04-03-2020
Patient Information leaflet Patient Information leaflet Lithuanian 04-03-2020
Summary of Product characteristics Summary of Product characteristics Lithuanian 04-03-2020
Public Assessment Report Public Assessment Report Lithuanian 04-03-2020
Patient Information leaflet Patient Information leaflet Hungarian 04-03-2020
Summary of Product characteristics Summary of Product characteristics Hungarian 04-03-2020
Public Assessment Report Public Assessment Report Hungarian 04-03-2020
Patient Information leaflet Patient Information leaflet Maltese 04-03-2020
Summary of Product characteristics Summary of Product characteristics Maltese 04-03-2020
Public Assessment Report Public Assessment Report Maltese 04-03-2020
Patient Information leaflet Patient Information leaflet Dutch 04-03-2020
Summary of Product characteristics Summary of Product characteristics Dutch 04-03-2020
Public Assessment Report Public Assessment Report Dutch 04-03-2020
Patient Information leaflet Patient Information leaflet Polish 04-03-2020
Summary of Product characteristics Summary of Product characteristics Polish 04-03-2020
Public Assessment Report Public Assessment Report Polish 04-03-2020
Patient Information leaflet Patient Information leaflet Portuguese 04-03-2020
Summary of Product characteristics Summary of Product characteristics Portuguese 04-03-2020
Public Assessment Report Public Assessment Report Portuguese 04-03-2020
Patient Information leaflet Patient Information leaflet Romanian 04-03-2020
Summary of Product characteristics Summary of Product characteristics Romanian 04-03-2020
Public Assessment Report Public Assessment Report Romanian 04-03-2020
Patient Information leaflet Patient Information leaflet Slovak 04-03-2020
Summary of Product characteristics Summary of Product characteristics Slovak 04-03-2020
Public Assessment Report Public Assessment Report Slovak 04-03-2020
Patient Information leaflet Patient Information leaflet Slovenian 04-03-2020
Summary of Product characteristics Summary of Product characteristics Slovenian 04-03-2020
Public Assessment Report Public Assessment Report Slovenian 04-03-2020
Patient Information leaflet Patient Information leaflet Finnish 04-03-2020
Summary of Product characteristics Summary of Product characteristics Finnish 04-03-2020
Public Assessment Report Public Assessment Report Finnish 04-03-2020
Patient Information leaflet Patient Information leaflet Swedish 04-03-2020
Summary of Product characteristics Summary of Product characteristics Swedish 04-03-2020
Public Assessment Report Public Assessment Report Swedish 04-03-2020
Patient Information leaflet Patient Information leaflet Norwegian 04-03-2020
Summary of Product characteristics Summary of Product characteristics Norwegian 04-03-2020
Patient Information leaflet Patient Information leaflet Icelandic 04-03-2020
Summary of Product characteristics Summary of Product characteristics Icelandic 04-03-2020
Patient Information leaflet Patient Information leaflet Croatian 04-03-2020
Summary of Product characteristics Summary of Product characteristics Croatian 04-03-2020

Search alerts related to this product

Alerts Picato Ингеноль mebutate ingenol

Picato Ингеноль mebutate ingenol

View documents history

Documents history Documents history

Picato